Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$7,089,064
+$122,769 QoQ
Shares Held
27,913
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#1,333
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BBR PARTNERS, LLC holds $25,619,055 across 7 Drug Manufacturers - General names. JNJ ranks #2 (27.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
53,615 | $13,491,678 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
27,913 | $7,089,064 | |
| 3 | AMGN |
Amgen Inc
|
5,580 | $2,020,629 | |
| 4 | LLY |
ELI LILLY & Co
|
1,523 | $1,826,732 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,889 | $512,184 | |
| 6 | PFE |
Pfizer Inc
|
18,751 | $451,524 | |
| 7 | NVS |
Novartis AG
|
1,450 | $227,244 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,089,064 | 27,913 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $6,966,295 | 28,499 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $6,331,842 | 30,596 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,497,146 | 29,647 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $4,507,805 | 29,511 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,694,101 | 28,305 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,100,700 | 28,355 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $4,452,436 | 27,474 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,545,695 | 24,259 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $5,151,140 | 32,563 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,709,722 | 23,668 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,510,222 | 16,117 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,870,944 | 17,345 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,925,780 | 18,876 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,368,538 | 19,069 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,264,749 | 19,985 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,721,852 | 20,967 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,538,751 | 19,967 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,048,659 | 6,130 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,109,828 | 6,872 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,082,177 | 6,569 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,248,073 | 7,594 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,192,310 | 7,576 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,426,121 | 9,579 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,993,008 | 14,172 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $2,813,656 | 21,457 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||